Why is post-treatment follow-up important?
Regular monitoring detects early relapse, manages side effects, and ensures optimal recovery.
Leukemia is a malignant disorder of the blood and bone marrow characterized by the uncontrolled proliferation of abnormal white blood cells. According to Robbins & Cotran Pathologic Basis of Disease, leukemia is defined as a clonal disorder of hematopoietic cells characterized by excessive accumulation of immature or dysfunctional leukocytes in the blood and bone marrow.
Aster Hospitals offer cutting-edge leukemia treatment through specialized clinics, led by a team of expert oncologists, hematologists, and transplant specialists. We adhere to international protocols and leverage advanced technology to deliver superior clinical outcomes. Our dedicated bone marrow transplant units provide comprehensive care for severe cases, ensuring the best possible treatment. With state-of-the-art diagnostic tools and a holistic approach, including nutritional and psychological support, we prioritize personalized patient care for faster recovery and better quality of life.
A leukemia specialist ensures precise diagnosis, personalized treatment plans, and long-term follow-up to monitor relapse and manage treatment complications. Advanced diagnostic tools, targeted therapies, and multidisciplinary care significantly improve patient outcomes.
Want to find out more about the treatment? The answer to your questions can be found below.
Early signs include persistent fatigue, frequent infections, easy bruising, and unexplained fever.
Treatment includes chemotherapy, targeted therapy, stem cell transplantation, and immunotherapy based on leukemia type.
Survival varies by type; ALL has a 90% childhood survival rate, while AML prognosis depends on genetic risk factors.
Diagnosis involves blood tests, bone marrow biopsy, and genetic studies to determine leukemia type and severity.
While not entirely preventable, reducing exposure to radiation, carcinogens, and smoking lowers the risk.
Regular monitoring detects early relapse, manages side effects, and ensures optimal recovery.
Regular monitoring detects early relapse, manages side effects, and ensures optimal recovery.
Survival varies by type; ALL has a 90% childhood survival rate, while AML prognosis depends on genetic risk factors.
While not entirely preventable, reducing exposure to radiation, carcinogens, and smoking lowers the risk.
Treatment includes chemotherapy, targeted therapy, stem cell transplantation, and immunotherapy based on leukemia type.
Diagnosis involves blood tests, bone marrow biopsy, and genetic studies to determine leukemia type and severity.
Early signs include persistent fatigue, frequent infections, easy bruising, and unexplained fever.
Personalized Medical Assistant for all your healthcare needs.
Book instant appointment, pay securely, eConsult with our doctors and save all your health records at one place are some of the benefits of OneAster App. It is everything you need, to manage your family Health.
* Registration available only for valid Indian mobile number